NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,404 | +0.9% | 2,959 | 0.0% | 0.10% | +3.0% |
| Q2 2023 | $298,593 | +13.5% | 2,959 | +3.5% | 0.10% | +3.1% |
| Q1 2023 | $263,028 | +86.1% | 2,859 | +53.8% | 0.10% | +43.3% |
| Q4 2022 | $141,303 | +0.2% | 1,859 | 0.0% | 0.07% | +1.5% |
| Q3 2022 | $141,000 | -10.2% | 1,859 | 0.0% | 0.07% | -22.4% |
| Q2 2022 | $157,000 | -3.7% | 1,859 | 0.0% | 0.08% | +4.9% |
| Q1 2022 | $163,000 | +117.3% | 1,859 | +116.4% | 0.08% | +113.2% |
| Q4 2021 | $75,000 | +7.1% | 859 | 0.0% | 0.04% | -5.0% |
| Q3 2021 | $70,000 | -11.4% | 859 | 0.0% | 0.04% | -9.1% |
| Q2 2021 | $79,000 | +8.2% | 859 | 0.0% | 0.04% | -8.3% |
| Q1 2021 | $73,000 | -9.9% | 859 | 0.0% | 0.05% | -20.0% |
| Q4 2020 | $81,000 | +3.8% | 859 | -9.4% | 0.06% | -25.0% |
| Q1 2020 | $78,000 | – | 948 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |